In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


The Camptothecins

Edited by Edited by Joachim Liehr and Beppino C. Giovanella (The Stehlin Foundation for Cancer Research, Houston) and Claire F. Verschraegen (M.D. Anderson Cancer Center, University of Texas, Houston)
The Camptothecins

Published: December 2000

Volume 922

Learn More

The extraordinary impact of camptothecin and its derivatives on topoiomerase I in preclinical studies on nude mice points to anticancer potential that has not yet been fully realized and developed. The 1996 Academy conference research on the camptothecins launched major advances in the understanding camptothecin's mechanisms of action (see vol. 803); the development of new derivatives; and pointed to a second generation of camptothecin-based chemotherapies. This volume unfolds this potential in four areas: mechanisms of action for the natural compound and current derivatives; chemical possibilities of modifying camptothecin; novel derivatives; novel routes of administration that enhance camptothecin's lactone ring stability, which appears vitally important for maintaining anticancer activity in humans. The science of camptopthecin-based anticancer is balanced by clinical and pharmacology topics including drug resistance, new analogues, and potential therapies for premature asthma and for bone marrow.

This volume is out of print.